Electroconvulsive therapy in neuroacanthocytosis or McLeod syndrome

Journal of ECT

Volumn 25, Issue 1, 2009, Pages 72-73

  Vázquez, Ma José Martín ^a   Martínez, María Carral ^a  

^a HOSPITAL SON LLÀTZER   (Spain)

Author keywords

Automutilations; ECT; Neuroacanthocytosis; Neurodegenerative illness; Subcortical dementia

Indexed keywords

ANTIBIOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CLOMIPRAMINE; CLONAZEPAM; CLOTIAPINE; CREATINE KINASE; DIAZEPAM; FLUOXETINE; HALOPERIDOL; MIRTAZAPINE; OLANZAPINE; PAROXETINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; SERTRALINE; NEUROLEPTIC AGENT;

ACANTHOCYTOSIS; ADULT; AGITATION; ANXIETY; ARTICLE; AUTOMUTILATION; AXONAL INJURY; BEHAVIOR DISORDER; CASE REPORT; CHOREA; CREATINE KINASE BLOOD LEVEL; DEPRESSION; DRUG DOSE REDUCTION; DYSAUTONOMIA; DYSTONIA; ELECTROCONVULSIVE THERAPY; ELLIPTOCYTOSIS; EMERGENCY WARD; FAMILIAL AMYLOID POLYNEUROPATHY; FATTY LIVER; FUNCTIONAL DISEASE; HEMOLYTIC ANEMIA; HOSPITALIZATION; HUMAN; INSOMNIA; MALE; MCLEOD SYNDROME; MENTAL DETERIORATION; NEUROACANTHOCYTOSIS; OBSESSIVE COMPULSIVE DISORDER; PARKINSONISM; PERSONALITY DISORDER; PSYCHIATRIC TREATMENT; PSYCHOTHERAPY; SPHEROCYTOSIS; TIC; TONGUE; URINARY TRACT INFECTION; FATALITY;

ADULT; ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; FATAL OUTCOME; HUMANS; MALE; NEUROACANTHOCYTOSIS; OBSESSIVE-COMPULSIVE DISORDER;

EID: 67649214101     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e31817b06e0     Document Type: Article

References (7)

1. Rampoldi L, Danek A, Monaco AP. Clinical features and molecular bases of neuroacanthocytosis. J Mol Med. 2002;80(8):475-491. (Pubitemid 34983912)
2. Habermeyer B, Fuhr P, Hiss B, et al. Obsessive-compulsive disorder due to neuroacanthocytosis treated with citalopram. Pharmacopsychiatry. 2006;39(5):193-194.
3. Habermeyer B, Fuhr P. Authors' reply: obsessive-compulsive disorders due to neuroacanthocytosis treated with citalopram. Pharmacopsychiatry. 2007;40(2):87. (Pubitemid 46697685)
4. Zwil AS, Pelchat RJ. ECT in the treatment of patients with neurological and somatic disease. Int J Psychiatry Med. 1994:24:1-29. (Pubitemid 24182833)
5. Beale MD, Kellner CH, Gurecki P, et al. ECT for the treatment of Huntington's disease: a case study. Convuls Ther. 1997;13(2):108-112. (Pubitemid 27329397)
6. Ranen NG, Peyser CE, Folstein SE. ECT as a treatment for depression in Huntington's disease. J Neuropsychol Clin Neurosci. 1994;6(2):154-159. (Pubitemid 24143944)
7. Kristjanson LJ, Aoun SM, Oldham L. Palliative care and support for people with neurodegenerative conditions and theirs carers. Int J Palliat Nurs. 2006;12(8):368-377.